James Samuel Shannon
Director at Xilio Therapeutics, Inc. (XLO)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+12.6%
vs. S&P 500-5.0%
Beat the market0%
Paper profit on buys+$1K
Total bought / sold$44K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 30SEC | XLOXilio Therapeutics, Inc. | Buy | 5,00010,000 held (+100%) | $8.79 | $44K | +3.0% |
- Buy
Director James Samuel Shannon bought $44K of XLO at $8.79 — first open-market purchase in our records; raises the stake by 100%.